INM

InMed Pharmaceuticals Inc. SEC filings

Every EDGAR filing for InMed Pharmaceuticals Inc. (INM), newest first, with AI summaries and stories.

Ticker
INM
CIK
1728328
Sector
Biotech and pharma
Latest filing
3d

Next: 10-Q expected ~Nov 12 (deadline Nov 16)

Watch in the app Get the app

Get an email when InMed Pharmaceuticals Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Insider activity

  • 10% owner bought $1K
  • 10% owner bought $11K
  • 10% owner bought $750

All INM insider trades

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  25. ROUTINE4InMed Pharmaceuticals Inc.INM

    2 insider filings

    Vivo Opportunity, LLC, insider filing for INM

    Show all 2
    • 4Insider filing for INM
    • 3New insider at INM

    Vivo Opportunity, LLC, reporting · Vivo Opportunity Cayman Fund, L.P., reporting · +2 more

  29. ROUTINE4InMed Pharmaceuticals Inc.INM

    2 insider filings

    Daniel Schneeberger, insider filing for INM

    Show all 2
    • 4Insider filing for INM
    • 3New insider at INM

    Daniel Schneeberger, reporting · ADAR1 Capital Management, LLC, reporting

  45. ROUTINE4InMed Pharmaceuticals Inc.INM

    4 insider filings

    Nicole Lemerond, insider filing for INM

    Show all 4
    • 4Insider filing for INM
    • 4Insider filing for INM
    • 4Insider filing for INM
    • 4Insider filing for INM

    Nicole Lemerond, reporting

Older filings on EDGAR